Xtandi
Ended Awarded
- Contract number
- VA24817F0523
- Awardee
-
Astellas Pharma US, Inc. UEI NKGHPQKJQWC1
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $243,162
Award facts
- Contract value 100% obligated
- $243,162.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- 112 Calle Arzuaga Ste 1, San Juan, 00925, Puerto Rico
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the delivery of the pharmaceutical drug XTANDI to the Veterans Health Administration (VHA) under the Pharmaceuticals and Drugs GSA Schedule contract. The $243,162.00 firm fixed price delivery order was awarded to Astellas Pharma US, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, and has an ultimate completion date of March 31, 2017. The contract was awarded without any set-aside designation. This order is part of a larger $3.5 billion federal supply schedule contract that Astellas holds with the VHA to provide pharmaceuticals and hematology-related products to VHA medical facilities. Additionally, Astellas has established two Blanket Purchase Agreements against this schedule contract to facilitate purchases of XTANDI, with potential values up to $296,500 through 2024 and over $1 million through 2021.
Quick answers
Who was awarded contract VA24817F0523?
VA24817F0523 was awarded to Astellas Pharma US, Inc. by Veterans Integrated Service Network 8 (Veterans Health Administration) on March 1, 2017.
How much is contract VA24817F0523 worth?
The government has obligated $243,162 on VA24817F0523.
Is contract VA24817F0523 an order under another contract?
Yes. VA24817F0523 is a delivery order under V797D30296, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA24817F0523 competed?
The extent of competition for VA24817F0523 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award